James Martin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Martin
James Martin is recorded as Chairman at PetVivo Holdings, Inc. (PETV) and CFO and CEO at Cocrystal Pharma, Inc. (COCP). The proxy statement of Cocrystal Pharma, Inc. reports total compensation of $627,201 for James Martin in fiscal 2023, including a base salary of $394,821. Disclosed compensation is on record for 6 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Start not stated–2022-01-18
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cocrystal Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- James Sapirstein CEO
- Sam Lee CEO
- Roger Kornberg Chairman
- Carol L. Brosgart Board Member
- Dr. Anthony Japour Board Member
- Dr. Phillip Frost Board Member
- Fred Hassan Board Member
- Mr. Richard C. Pfenniger, Jr. Board Member
- Mr. Roger Kornberg Board Member
- Mr. Steven Rubin Board Member
Leadership on record at PetVivo Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- John Lai CEO, Board Member
- Garry Lowenthal CFO
- John Dolan General Counsel
- Jaime K. Pickett Board Member
- Josh Ruben Board Member
- Leslie Coolidge Board Member
- Michael K. Handley Board Member
- Mike Eldred Board Member
- Rob Costantino Board Member
- Robert Costantino Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Cocrystal Pharma, Inc. (COCP) | Co-Chief Executive Officer and Chief Financial Officer | $394,821 | $627,201 |
| 2022 | Cocrystal Pharma, Inc. (COCP) | Co-Chief Executive Officer and Chief Financial Officer | $371,384 | $621,588 |
| 2021 | Cocrystal Pharma, Inc. (COCP) | Co-Chief Executive Officer and Chief Financial Officer | $332,500 | $665,000 |
| 2020 | Cocrystal Pharma, Inc. (COCP) | Co-Interim Chief Executive Officer and Chief Financial Officer | $281,000 | $492,000 |
| 2019 | Cocrystal Pharma, Inc. (COCP) | Chief Financial Officer | $231,000 | $231,000 |
| 2018 | Cocrystal Pharma, Inc. (COCP) | Chief Financial Officer | $230,836 | $549,866 |
Recent activity
No call appearances or filed executive changes recorded yet.